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Hypertrabeculation vs Left Ventricular Noncompaction
on Echocardiogram
A Reason to Restrict Athletic Participation?
David C. Peritz, MD; Aaron Vaughn, MD; Mario Ciocca, MD; Eugene H. Chung, MD
L eft ventricular noncompaction (LVNC) was first recog-nized in 19321 but was not officially described until 1990.2Thought to be secondary to the arrest of normal myocar-
dial development, LVNC results in multiple deep trabecula-
tions in the left ventricle.3 Clinical manifestations vary widely
from asymptomatic to progressive deterioration resulting in
heart failure.4 Left ventricular noncompaction is considered a
cause of sudden cardiac death due to severe systolic dysfunc-
tion and fatal arrhythmias. Reports of sudden death in those with
LVNC range between 2% and 62%, with one recent study re-
porting a death rate of 5% occurring exclusively in patients with
a history of symptomatic heart failure, chest pain, syncope, or
episodes of palpitations.5 Up to 40% of patients with LVNC have
some evidence of familial disease.3 We report a case of an asymp-
tomatic college athlete whose potential diagnosis of LVNC was
first discovered on a preparticipation physical examination. Ap-
proval from the institutional review board was waived, but writ-
ten consent was obtained from the patient.
Report of a Case
An 18-year-old African American male football player sought
treatment at a cardiology clinic after a murmur was heard dur-
ing his preparticipation physical examination. He had no symp-
toms of chest pain, lightheadedness, dizziness, or syncopal or
presyncopal episodes. His medical history was significant for
well-controlled asthma. Family history was negative for pre-
mature coronary disease, heart failure, or sudden death of any
kind. At presentation, his vital signs were within normal lim-
its, and the examination showed no abnormalities except for
a soft systolic murmur.
A 12-lead electrocardiogram showed sinus rhythm, sinus
arrhythmia, anterior early repolarization pattern, inverted T
wave in V1, and biphasic T wave in lead III (Figure 1). Given
the new murmur, an echocardiogram was ordered and re-
vealed hypertrabeculation but normal systolic function
(Figure 2). Cardiac magnetic resonance imaging (MRI) dem-
onstrated apical hypertrabeculation without evidence of seg-
mental myocardial thinning and normal apical contractility
(Figure 3). The differential diagnosis at this point was normal
variant hypertrabeculation left ventricle vs LVNC.
Out of concern for LVNC, and in accordance with the 36th
Bethesda Guidelines, the patient was advised to refrain from
intense exertional activity.6 Given his strong desire to play foot-
ball, we sought the opinions of two nationally known experts
on cardiomyopathies. Expert 1 performed an exercise stress
echocardiogram, which was unremarkable. A transthoracic
IMPORTANCE Left ventricular noncompaction (LVNC) is a rare cause of progressive
cardiomyopathy thought to result from incomplete myocardial development. It has been
associated with an increased risk of sudden death, especially in those with a depressed left
ventricular ejection fraction. Thus, the current recommendation for patients with this
diagnosis is restriction from participation in competitive sports.
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echocardiogram showed a thick to thin compacted layer ratio
of 3.2:1, consistent with a diagnosis of LVNC (Zurich and Mil-
waukee echocardiogram criteria >2:1).7 Expert 1’s interpreta-
tion of our MRI confirmed the diagnosis of LVNC, showing
prominent trabeculations in the left ventricular cavity extend-
ing to the apex, and established a ratio of nontrabeculated to
compacted myocardium of 3:1 (Petersen MRI criteria ratio
>2.3:1).8,9 A 24-hour Holter monitor to rule out nonsustained
ventricular tachycardia and aspirin, 81 mg/d, for stroke pre-
vention were recommended. An implantable cardiac defib-
rillator was deferred since the patient was asymptomatic with
a preserved ejection fraction. Notably, Expert 1 recom-
mended that the patient continue to refrain from organized
sports and avoid “burst exertional” activity, although recre-
ational aerobic activity would be regarded as safe.
Expert 2 performed an exercise treadmill test, which was
negative for arrhythmia. A transthoracic echocardiogram again
showed an ejection fraction of 60% and left ventricular tra-
beculations at the apex potentially consistent with LVNC. How-











showing sinus rhythm, sinus
arrhythmia, anterior early
repolarization pattern, inverted
T wave in V1, and biphasic T wave in
lead III.
Figure 2. Echocardiogram Revealing Hypertrabeculation






























A, Increased ventricular wall thickness. The left ventricular ejection fraction is
more than 55%. B, Prominent trabeculation of the apical portion of the left
ventricle with deep intertrabecular recesses. Arrowhead in each view indicates
area of hypertrabeculation.
Figure 3. Magnetic Resonance Imaging: Apical Hypertrabeculation
Without Segmental Myocardial Thinning
Magnetic resonance image showing no apical thrombi and no evidence of
systolic dysfunction. Arrowhead indicates area of hypertrabeculation.
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ever, the noncompacted to compacted segment ratio deter-
mined was 1.8, which did not meet the criteria for LVNC.7 A
24-hour Holter monitor again did not record any ventricular
ectopy. Expert 2 concluded that, given normal wall motion as
well as a normal enhancement pattern without evidence of
strain, this case represented a “normal variant in a black ath-
lete” rather than pathologic LVNC. Furthermore, unlike Ex-
pert 1, Expert 2 recommended that the patient be allowed to
return to full athletic competition but repeat the 24-hour Holter
monitor and cardiac MRI in 2 to 3 months. In addition, it was
proposed that all first-degree relatives undergo echocardio-
graphic screening.
Discussion
The discussions with the consultants were reviewed with the
patient, family, and the team physicians. We decided that de-
spite conflicting opinions and a likely low yet unquantified risk
of sudden death, it would be in the patient’s best interest to
return to play. The patient returned to full athletic participa-
tion. He has performed very well, has remained asymptom-
atic, and is reevaluated annually. Family screening echocar-
diograms have been negative for abnormalities.
Left ventricular noncompaction is characterized by a
prominent trabecular meshwork and deep intratrabecular re-
cesses that extend into the left ventricular wall. It is believed
to be caused by the arrest of normal intrauterine myocardial
morphogenesis.2 Left ventricular noncompaction is an ex-
tremely rare cardiomyopathy with a prevalence of less than
0.3% in the adult population.3 Hypertrabeculation also can be
seen in association with a number of other cardiac abnormali-
ties as well as in the healthy heart. In the largest study of its
kind, Gati et al10 used echocardiography to show that ath-
letes had a higher prevalence of hypertrabeculation com-
pared with nonathletes (18.3% vs 7%). This finding was even
more pronounced in African and Afro-Caribbean athletes, but
only a small proportion experienced systolic dysfunction and
marked repolarization suggestive of cardiomyopathy. Captur
et al11 applied fractal geometry analysis to cardiac MRI to quan-
tify left ventricular trabeculation. They showed increased tra-
beculation in healthy African Americans compared with
healthy whites. Interestingly, a large proportion of patients with
sickle cell disease demonstrate increased left ventricular tra-
beculation that meets diagnostic criteria for LVNC, while it is
unlikely they have LVNC.12 It was hypothesized that hyper-
trabeculation could be an ethnically determined adaptation to
increased preload seen in both sickle cell disease and athletic
training.
Typical clinical manifestations of LVNC that occur equally
in adults and children include the triad of heart failure, arrhyth-
mia, and embolic events.2 Electrocardiographic findings often
demonstrate left ventricular hypertrophy with increased volt-
ages, inverted T waves, and Wolff-Parkinson-White syndrome.13
There is no pathognomonic histologic feature to aid in the di-
agnosis of LVNC, although fibrosis has been reported.14 Diag-
nosis is usually made using echocardiography with increasing
use of cardiac MRI. Jenni et al7 defined LVNC as a ratio of the
thick noncompact layer to the thin compact layer of more than
2.0, as measured in the short-axis view. Using MRI, Petersen et
al8 defined LVNC as a ratio between noncompact and compact
layers of more than 2.3 at end-diastole. Magnetic resonance
imaging technology has improved the definition of the anatomy
but is not as accessible as echocardiography, especially in the
context of preparticipation screening.
The patient’s case emphasizes the caveats of preparticipa-
tion screening. He was a highly recruited athlete expected to
compete at an extreme level, and obtaining an echocardio-
gram to assess a new murmur was reasonable. The incidental
findings suggestive of LVNC, beyond the obvious medical im-
pact, could have curtailed his collegiate career immediately as
well as his prospects as a professional athlete. We were faced
with a controversial diagnosis that, unlike conditions such as
hypertrophic cardiomyopathy and long QT syndrome, has lim-
ited data associated with it to guide management. Regardless
of guidelines, expert consultation should be considered in chal-
lenging cases such as ours to provide the patient and family and
his or her health care providers with as much information as pos-
sible before deciding on participation or restriction.
Conclusions
To our knowledge, no reported cases of sudden death in ath-
letes have been attributed to LVNC. We expect as imaging mo-
dalities continue to improve and as preparticipation screen-
ing becomes more prevalent, scenarios such as ours will
become increasingly common. Patients with hypertrabecula-
tion but preserved left ventricular function may represent a
low-risk group. Close follow-up along with longitudinal reg-
istry studies will continue to be important to establishing risk
in patients such as ours.
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